Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation-Reference-Cited by-同舟云学术

Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation

Published:2016-09 Issue:3 Volume:30 Page:404-417
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Obeng Esther A.,Chappell Ryan J.,Seiler Michael,Chen Michelle C.,Campagna Dean R.,Schmidt Paul J.,Schneider Rebekka K.,Lord Allegra M.,Wang Lili,Gambe Rutendo G.,McConkey Marie E.,Ali Abdullah M.,Raza Azra,Yu Lihua,Buonamici Silvia,Smith Peter G.,Mullally Ann,Wu Catherine J.,Fleming Mark D.,Ebert Benjamin L.

Funder

NIH

American Society of Hematology

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference55 articles.

1. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A);Allikmets;Hum. Mol. Genet.,1999

2. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage;Alsafadi;Nat. Commun.,2016

3. Mouse models of myelodysplastic syndromes;Beachy;Hematol. Oncol. Clin. North Am.,2010

4. Prp40 and early events in splice site definition;Becerra;Wiley Interdiscip. Rev. RNA,2015

5. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;N. Engl. J. Med.,2011

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SF3B1-mutant mis-splicing ofUBA1confers a targetable therapeutic vulnerability through UBA1 inhibition;2024-08-28

2. RNA binding protein‐directed control of leukemic stem cell evolution and function;HemaSphere;2024-08

3. Molecular impact of mutations in RNA splicing factors in cancer;Molecular Cell;2024-08

4. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition;Leukemia;2024-07-13

5. Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition;Blood Cancer Discovery;2024-06-07